Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 44, 3196-3201, August 1, 1984]
© 1984 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crum, E. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crum, E. D.

Subsets of Circulating T-Lymphocytes Mediating Resistance to in Vivo Growth of a Carcinogen-induced Syngeneic Rat Tumor1

Edward D. Crum

Hematology/Oncology Section, Veterans Administration Medical Center, and Case Western Reserve University School of Medicine, Cleveland, Ohio 44106

Wistar rats immunized by s.c. implantation of irradiated Mc7 sarcoma tissue were resistant to the growth of a challenge of this chemical carcinogen-induced syngeneic tumor. Lymphocyte populations enriched in each of the two major T-cell lineages recognized by mouse monoclonal antibodies were prepared from the thoracic duct lymphocyte pool of tumor-resistant rats by affinity chromatography and infused i.v. into normal syngeneic rats. The recipients of either one donor equivalent of "helper" T-cells identified by the monoclonal antibody W3/25 or one donor equivalent of "nonhelper" T-cells identified by the monoclonal antibody OX-8 were resistant to a challenge of Mc7 sarcoma cells. Contaminating cells do not appear to account for the activities of each enriched population, indicating that lymphocytes contributing to expression of resistance to in vivo growth of Mc7 sarcoma must be present in both the helper and the nonhelper T-cell lineages. No direct cytotoxic activity by the thoracic duct lymphocyte populations against the Mc7 sarcoma cells could be demonstrated in vitro. These lymphocytes were generated in vivo and delivered to the systemic circulation of tumor-resistant hosts, implying they play a role in the expression of antitumor resistance in the intact immunized donor.

1 Supported by Medical Research Service, Veterans Administration Medical Center, Cleveland, OH.

Received 1/ 9/84. Accepted 4/26/84.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1984 by the American Association for Cancer Research.